-
Financial News
/ 3 months agoDuolingo stock skyrockets 30% on boosted guidance as AI powers user growth
Duolingo shares skyrocketed after the language learning platform boosted its guidance due to strong user growth driven by artificial intelligence.Read More
-
Financial News
/ 3 months agoWhat private assets in 401(k) plans mean for investors: ‘You’re only asking for trouble,’ one advisor says
Millions of investors may soon have access to private assets in their 401(k) or other workplace retirement plans. What to know...
-
Financial News
/ 3 months agoTrump order will allow alternative assets like cryptocurrencies, private equity in 401(k)s
The executive order will direct the U.S. Secretary of Labor to review fiduciary guidance on private market investments in 401(k) and...
-
Financial News
/ 3 months agoIntel shares drop after Trump calls for CEO to resign immediately
Intel shares were under pressure Thursday after President Donald Trump called for the chipmaker’s CEO to resign immediately.Read More
-
Financial News
/ 3 months agoStocks making the biggest moves premarket: Eli Lilly, Peloton, Intel, Duolingo and more
These are the stocks posting the largest moves in premarket trading.Read More
-
Financial News
/ 3 months agoEli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss...
-
Financial News
/ 3 months agoIndia isn’t flinching: Why Trump might be misreading India’s tariff playbook
Washington may be mistaking India’s complaisance for America’s leverage.Read More
-
Financial News
/ 3 months agoNew federal student loan limits are a ‘punch in the face’ for aspiring doctors: American Medical Association president
Trump’s “big beautiful bill” caps medical school loans, which may make it harder for future doctors to finance their degree or...
-
Financial News
/ 3 months agoEli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval
Eli Lilly’s pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight...
-
Financial News
/ 3 months agoTrump’s latest chip tariff announcement raises more questions than answers
U.S. President Donald Trump has divulged more of his semiconductor tariff plans, but his latest threats create as many questions than...


